Dr. JOHAN ABELOOS
ActiveSummary
Dr. JOHAN ABELOOS has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €846,017 and a net result of €86,416. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 75% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DR. JOHAN ABELOOS
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “beslissingen nemen die de eerbiediging van de medische deontologie door de arts-aandeelhouder ondermijnen. Het bestuursorgaan dat het orgaan…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Bepaalde of onbepaalde termijn, een of meer” (deed in Dutch)2 more provisions on this in the deed
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Beperkt door statuten” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of June at 20:00
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed